Oxygen Therapy Clinical Trials
- Effect of High Levels of Oxygen and Smoking on the Lungs in Human Volunteers
ClinicalTrials.gov Identifier: NCT00001464 - Active, not recruiting
Healthy; Hyperoxia
- Complementary Hyperbaric Oxygen for Brain Tissue Damage Caused by Radiation Therapy
ClinicalTrials.gov Identifier: NCT00087815 - Active, not recruiting
Abnormalities, Radiation Induced
- Radiation Therapy Plus Hyperbaric Oxygen in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00006460 - Active, not recruiting
adult glioblastoma multiforme
- Non-Invasive Ventilation and Oxygen Therapy in Cystic Fibrosis Patients with Nocturnal Oxygen Desaturation
ClinicalTrials.gov Identifier: NCT00157183 - Recruiting
Cystic Fibrosis
- Study to Determine If Hyperbaric Oxygen Therapy is Helpful for Treating Radiation Tissue Injuries.
ClinicalTrials.gov Identifier: NCT00134628 - Recruiting
Radiation Injuries; Prophylaxis
- Hyperbaric Oxygen Therapy Compared With Standard Therapy in Treating Chronic Arm Lymphedema in Women Who Have Undergone Radiation Therapy for Early Breast Cancer
ClinicalTrials.gov Identifier: NCT00077090 - Active, not recruiting
Lymphedema; Radiation Fibrosis; perioperative/postoperative complications; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (the STOP-ROP Multicenter Trial)
ClinicalTrials.gov Identifier: NCT00000141 - Active, not recruiting
Retinopathy of Prematurity
- Method of Oxygen Delivery and the Effect on Transcutaneous PaCO2
ClinicalTrials.gov Identifier: NCT00135252 - Recruiting
developing chronic lung disease
- Benefits of Lightweight Ambulatory Oxygen Systems for Individuals With Chronic Obstructive Pulmonary Disease (COPD) Who Need Supplemental Oxygen
ClinicalTrials.gov Identifier: NCT00325754 - Active, not recruiting
Pulmonary Disease, Chronic Obstructive
- Normobaric Oxygen Therapy in Acute Ischemic Stroke Trial
ClinicalTrials.gov Identifier: NCT00414726 - Recruiting
Stroke
- Effects of Hyperbaric Oxygen Therapy on Children With Autism
ClinicalTrials.gov Identifier: NCT00406159 - Recruiting
Autism
- Transrectal Tumour Oxygen - US Army
ClinicalTrials.gov Identifier: NCT00160979 - Recruiting
Prostatic Neoplasms
- The Influence of a Warmed Surgical Bandage System on Subcutaneous Tissue Oxygen Tension After Cardiac Surgery
ClinicalTrials.gov Identifier: NCT00545506 - Not yet recruiting
Tisssue Oxygen Tension; Tissue Temperature
- Hyperbaric Oxygen Therapy and Angiogenesis in Diabetic Patients With Foot Ulcers
ClinicalTrials.gov Identifier: NCT00475202 - Recruiting
Diabetic Foot Ulcers; Hyperbaric Therapy; Angiogenesis
- Efficacy of Hyperbaric Oxygen Therapy in Laryngectomy Patients
ClinicalTrials.gov Identifier: NCT00026975 - Completed
Laryngeal Cancer
- Hormone Therapy in Treating Patients With Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003026 - Active, not recruiting
adenocarcinoma of the prostate
- Oxygen Therapy in Schizophrenia
ClinicalTrials.gov Identifier: NCT00525863 - Not yet recruiting
Chronic Schizophrenia
- Use of Blended Oxygen for Delivery Room Resuscitation of Very Low Birth Weight Infants
ClinicalTrials.gov Identifier: NCT00369720 - Active, not recruiting
Prematurity; Oxidant Injury
- Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00049374 - Active, not recruiting
refractory plasma cell neoplasm
- Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
ClinicalTrials.gov Identifier: NCT00004024 - Active, not recruiting
adult brain tumor
- Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00023959 - Active, not recruiting
Head and Neck Cancer
- Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma
ClinicalTrials.gov Identifier: NCT00006480 - Active, not recruiting
disseminated neuroblastoma; Drug Toxicity; recurrent neuroblastoma
- SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00026377 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
- Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases
ClinicalTrials.gov Identifier: NCT00033254 - Active, not recruiting
brain metastases
- Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00055913 - Active, not recruiting
Head and Neck Cancer
- Vaccine Therapy and/or Sargramostim in Treating Patients With Locally Advanced or Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00005034 - Active, not recruiting
intraocular melanoma; Melanoma
- Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00014560 - Active, not recruiting
Lymphocytic Lymphoma; Non-Hodgkin's Lymphoma
- The Role of Reactive Oxygen Species in Ischaemia-Reperfusion Injury of the Transplanted Kidney
ClinicalTrials.gov Identifier: NCT00204178 - Active, not recruiting
Kidney Transplantation
- Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00082823 - Active, not recruiting
Cancer
- Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00083213 - Active, not recruiting
Cancer
- Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00006385 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Combination Chemotherapy and Filgrastim Followed by Radiation Therapy in Treating Patients With Stage II or Stage IIIA Breast Cancer
ClinicalTrials.gov Identifier: NCT00007904 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; Male Breast Cancer
- Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma
ClinicalTrials.gov Identifier: NCT00002560 - Active, not recruiting
recurrent neuroblastoma
- Enzastaurin in Treating Patients With Recurrent Gliomas
ClinicalTrials.gov Identifier: NCT00112788 - Active, not recruiting
adult brain tumor
- Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00128700 - Active, not recruiting
adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
- Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00182689 - Active, not recruiting
Lung Cancer
- Biological Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002786 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Biological Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00045149 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00067015 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer; Quality of Life
- Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00096512 - Active, not recruiting
Head and Neck Cancer
- Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/neu-Expressing Cancer
ClinicalTrials.gov Identifier: NCT00084513 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00091299 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00108732 - Active, not recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00089206 - Active, not recruiting
intraocular melanoma; Melanoma
- Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00028678 - Active, not recruiting
adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
- Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients with Locally Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00016913 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer
- Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
ClinicalTrials.gov Identifier: NCT00006734 - Active, not recruiting
localized tumors of the Ewing's family
- Cetuximab, Combination Chemotherapy, and Radiation therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00109850 - Active, not recruiting
Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus; stage III esophageal cancer
- Antineoplaston Therapy in Treating Patients With Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00003456 - Active, not recruiting
adult glioblastoma
- Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00006113 - Active, not recruiting
stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003653 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00084708 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00104884 - Active, not recruiting
intraocular melanoma; Melanoma
- Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00040950 - Active, not recruiting
adult non-Hodgkin's lymphoma
- Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00054522 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00015977 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00006359 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00007826 - Active, not recruiting
Colon Cancer; Rectal Cancer
- Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease
ClinicalTrials.gov Identifier: NCT00003414 - Active, not recruiting
Lymphoma
- Sorafenib in Treating Patients with Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00119249 - Active, not recruiting
Stage IV Melanoma
- Palliative Oxygen for the Relief of Breathlessness
ClinicalTrials.gov Identifier: NCT00327873 - Recruiting
Dyspnea
- GW786034 in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00060151 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00005959 - Active, not recruiting
Lymphoma
- Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00089219 - Active, not recruiting
intraocular melanoma; Melanoma
- Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00089115 - Active, not recruiting
grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma
- Combination Chemotherapy in Treating Women With Stage I Breast Cancer
ClinicalTrials.gov Identifier: NCT00055679 - Active, not recruiting
stage I breast cancer
- Brief Strategic Family Therapy for Adolescent Drug Abusers - 1
ClinicalTrials.gov Identifier: NCT00095303 - Active, not recruiting
Behavior Therapy
- Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx
ClinicalTrials.gov Identifier: NCT00004227 - Active, not recruiting
Oral Cancer; Throat Cancer
- Epoetin alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00060398 - Active, not recruiting
recurrent prostate cancer; Anemia; Fatigue
- Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00058006 - Active, not recruiting
Head and Neck Cancer; thorax and respiratory cancer
- Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00005044 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
- Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
ClinicalTrials.gov Identifier: NCT00217620 - Active, not recruiting
adult soft tissue sarcoma
- Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas
ClinicalTrials.gov Identifier: NCT00003113 - Active, not recruiting
Lymphoma
- Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00098475 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- PEG-Interferon alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00090870 - Active, not recruiting
Stage IV Renal Cell Cancer
- Sorafenib With or Without Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00126594 - Active, not recruiting
renal clear cell carcinoma; Stage IV Renal Cell Cancer
- Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00053768 - Active, not recruiting
adult non-Hodgkin's lymphoma
- Tipifarnib in Treating Patients With Metastatic Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00060125 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of the HER2/neu Protein
ClinicalTrials.gov Identifier: NCT00004074 - Active, not recruiting
Cancer
- Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00012233 - Active, not recruiting
Stage IV rectal cancer; stage IV colon cancer
- Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00080873 - Active, not recruiting
Cancer; oral complications of cancer and cancer therapy
- Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00126490 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Interleukin-12 and Interferon alfa in Treating Patients With Metastatic Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00026143 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors
ClinicalTrials.gov Identifier: NCT00003478 - Active, not recruiting
adult brain tumor
- ZD6474 and Docetaxel in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00054093 - Active, not recruiting
Non-small cell lung cancer
- Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00049296 - Active, not recruiting
Cancer
- SU5416 in Treating Children With Recurrent or Progressive Brain Tumors
ClinicalTrials.gov Identifier: NCT00006247 - Active, not recruiting
Brain Cancer
- Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors
ClinicalTrials.gov Identifier: NCT00003484 - Active, not recruiting
Central Nervous System Tumor; Brain Tumor
- Erlotinib and Bevacizumab in Treating Women With Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00054132 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
- Vaccine Therapy in Treating Patients With Primary Stage II Melanoma
ClinicalTrials.gov Identifier: NCT00005052 - Active, not recruiting
stage II melanoma
- Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00027729 - Active, not recruiting
recurrent colon cancer; recurrent rectal cancer
- Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00104988 - Active, not recruiting
Stage IV Melanoma
- SU011248 in Treating Women With Metastatic Breast Cancer That Did Not Respond to Anthracycline or Taxane Chemotherapy
ClinicalTrials.gov Identifier: NCT00095615 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00017355 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Standard Whole Brain Radiation Therapy with Supplemental Oxygen, with or without Concurrent RSR13 (efaproxiral), in Women with Brain Metastases from Breast Cancer
ClinicalTrials.gov Identifier: NCT00083304 - Completed
Breast Cancer; Metastases
- Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00009776 - Active, not recruiting
Burkitt's Lymphoma; Lymphocytic Lymphoma
- Thalidomide in Treating Patients With Myelofibrosis
ClinicalTrials.gov Identifier: NCT00015821 - Active, not recruiting
Agnogenic Myeloid Metaplasia
- Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00009763 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00016146 - Active, not recruiting
recurrent prostate cancer
- Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00047294 - Active, not recruiting
Mixed Gliomas; adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
